SSA
LMAT icon

Schonfeld Strategic Advisors’s LeMaitre Vascular LMAT Stock Holding History

Schonfeld Strategic Advisors’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-11,960
Closed -$993K – 2409
2025
Q2 		$993K Buy
+11,960
New +$1,000K 0.01% 1312

Other funds holding LMAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Schonfeld Strategic Advisors's LMAT Position: Q3 2025 in Review

Schonfeld Strategic Advisors sold out of LeMaitre Vascular (LMAT) in Q3 2025, closing a stake of 11,960 shares — an estimated $993K sold.

Schonfeld Strategic Advisors first reported a position in LMAT in Q2 2025 and held it in 1 quarter. The position peaked at $993K in Q2 2025. 297 funds tracked by Wall St. Rank hold LMAT as of Q3 2025.

  • Schonfeld Strategic Advisors reported no remaining LeMaitre Vascular position as of Q3 2025 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 11,960 LeMaitre Vascular shares in Q3 2025, an estimated $993K.
  • Schonfeld Strategic Advisors first reported a position in LeMaitre Vascular in Q2 2025 and held it in 1 quarter.
  • Schonfeld Strategic Advisors's LeMaitre Vascular position peaked at $993K in Q2 2025.
  • 297 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q3 2025.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.